Abordaje contemporáneo a infecciones complejas: 3º Parte

1. DiNubile MJ, Lipsky BA. Complicated infections of skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother. 2004;53(suppl 2):ii37-ii50.
2. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373-1406.
3. Dellinger EP. Nosocomial infection. In: Wilmore DW, Cheung LY, Harken AH, Holcroft JW, Meakins JL, Soper NJ, eds. ACS Surgery: Principles and Practice. New York, NY: WebMD Professional Publishing; 2002:12211238.
4. Weinstein RA. Hospital-acquired infections. In: Kasper DL, Braunwald E, Fauci AS, Hauswer S, Longo D, Jameson JL, eds. Harrison''s Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill Medical; 2006.
5. Livesley NJ, Chow AW. Infected pressure ulcers in elderly individuals. Clin Infect Dis. 2002;35:1390-1396.
6. Headley AJ. Necrotizing soft tissue infections: a primary care review. Am Fam Physician. 2003;68:323-328.
7. Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85-A:1454-1460.
8. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445-1453.
9. Stevens DL, Bryant AE. The role of clostridial toxins in the pathogenesis of gas gangrene. Clin Infect Dis. 2002;35(suppl 1):S93-S100.
10. Belda FJ, Aguilera L, García de la Asunción J, et al, for the Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA. 2005;294:2035-2042.
11. Dellinger EP. Increasing inspired oxygen to decrease surgical site infection: time to shift the quality improvement research paradigm [editorial]. JAMA. 2005;294:2091-2092.
12. Rennie RP, Jones RN, Mutnick AH; SENTRY Program Study Group (North America). Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diagn Microbiol Infect Dis. 2003;45:287-293.
13. Blondeau JM. The role of fluoroquinolones in skin and skin structure infections. Am J Clin Dermatol. 2002;3:37-46.
14. Raghavan M, Linden PK. Newer treatment options for skin and soft tissue infections. Drugs. 2004;64:1621-1642.
15. Padmanabhan RA, Larosa SP, Tomecki KJ. What''s new in antibiotics? Dermatol Clin. 2005;23:301-312.
16. Giordano P, Song J, Pertel P, Herrington J, Kowalsky S. Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection. Int J Antimicrob Agents. 2005;26:357-365.